SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Focused Visit (Care-plan review) — Jean-Jacques Rousseau

PatientJean-Jacques Rousseau
Date of birth1971-06-28
IdentifiersMRN HR-EN003-SYN; SSN (made up) 000-03-2716
Document date2026-07-14
AuthorCelestine Marchetti-Owusu, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Twelve-week review on aripiprazole; urethroplasty follow-up. [S]

History of Present Illness

Mr. Rousseau returns twelve weeks after starting aripiprazole 5 mg and about sixteen weeks after urethroplasty. He sleeps about six and a half hours most nights. He still believes some former friends speak against him, but he now spends under an hour a day on these thoughts rather than most of the day, opens his letters, and has written most mornings for a month. He has had fourteen CBT sessions and plans two more. He has had no restlessness, nausea, stiffness, or new urges, and has taken the tablet every morning. The four-week weight check was missed while he was away walking in the hills; his weight was taken at the sick visit for back strain five weeks ago, which has fully resolved. He passes urine freely and gets up once at night at most. He has had no thoughts of suicide or of harming anyone. [S]

ElementDetail
SleepAbout six and a half hours
BeliefsPresent, held less firmly; under an hour a day of preoccupation
MedicationAripiprazole 5 mg daily; no side effects; no missed doses
PsychotherapyFourteen CBT sessions
VoidingFree stream; up once at night at most
Back strainResolved within three weeks
SafetyNo thoughts of suicide or of harming anyone

Review of Systems

SystemResultFinding
ConstitutionalNegativeWeight up slightly; no fatigue
GenitourinaryNegativeStrong stream; no spraying, burning, or blood
MusculoskeletalNegativeBack pain resolved
NeurologicalNegativeNo restlessness, tremor, stiffness, or abnormal movements
EndocrineNegativeNo thirst or excessive urination
PsychiatricPositivePersecutory beliefs persist with less conviction and distress; no hallucinations; no new urges; no thoughts of suicide or of harming anyone

6 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for pain, no more than 3000 mg a dayTwo tablets up to every 8 hours as neededOral route2026-03-24activeS
Aripiprazole 5 mg oral tablet, one tablet by mouth each morningOne tablet each morningOral route2026-04-21activeS
Ibuprofen 400 mg oral tablet, one tablet by mouth three times a day with food for up to seven daysOne tablet three times a day with foodOral route2026-06-09 to 2026-06-16completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-07-14Body height166cmS
2026-07-14Body weight64.4kgS
2026-07-14Body mass index (BMI) [Ratio]23.4kg/m2S
2026-07-14Systolic blood pressure124mm[Hg]S
2026-07-14Diastolic blood pressure78mm[Hg]S
2026-07-14Heart rate72/minS
2026-07-14Respiratory rate14/minS
2026-07-14Body temperature36.6CelS
2026-07-14Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-07-14Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
2026-07-14Symptom score [AUASI]5{score}S
2026-07-14If you were to spend the rest of your life with your urinary condition just the way it is now, how would you feel about that [IPSS]1{score}S
2026-07-14Maximum Urine flow by Uroflowmetry20.8mL/sA maximum flow of 15 mL/s or more is normal for a voided volume above 150 mLNormalS
2026-07-14US Urinary bladder Volume post void30mL<=100 mLNormalS
2026-07-14Creatinine [Mass/volume] in Serum or Plasma0.99mg/dL0.74-1.35 mg/dLNormalS
2026-07-14Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M91mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-07-14Glucose [Mass/volume] in Serum or Plasma94mg/dL70-99 mg/dLNormalS
2026-07-14Hemoglobin A1c/Hemoglobin.total in Blood5.5%<=5.6%NormalS
2026-07-14Cholesterol [Mass/volume] in Serum or Plasma201mg/dL<=199 mg/dLHighS
2026-07-14Cholesterol in HDL [Mass/volume] in Serum or Plasma47mg/dL>=40 mg/dLNormalS
2026-07-14Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation126mg/dL<=129 mg/dLNormalS
2026-07-14Triglyceride [Mass/volume] in Serum or Plasma138mg/dL<=149 mg/dLNormalS
2026-07-14Waist Circumference at umbilicus by Tape measure93cmBelow 102 cm for menNormalS

Physical Exam

Vital signs recorded on 2026-07-14; see the Vital Signs section. [S]

SystemFinding
GeneralWell and relaxed
NeurologicalNo tremor, rigidity, or involuntary movements; no akathisia
GenitourinaryPerineal scar healed; right inguinal hernia small and reducible, unchanged
BackFull, painless movement
Mental statusWarm and courteous; mood "steadier than for years"; persecutory beliefs present but held with less conviction, and he can consider other explanations; no hallucinations; no suicidal or violent ideation

Problems

ProblemClinical statusVerificationCodeProvenance
Fixed beliefs that former friends and colleagues are plotting to ruin him, with poor sleep, present for years and worse over the past year; cause not yet established; psychiatric and medical assessment under wayresolvedconfirmed R46.5S — Synthetic presenting concern at the index visit, superseded by the diagnosis at the psychiatry consultation; his documented beliefs of 1766 are echoed.
Weak urinary stream, straining, incomplete emptying (post-void residual 180 mL), and painful urination since childhood, treated for years by self-dilation with urethral sounds; cause not yet established; urethral imaging and endoscopy bookedresolvedconfirmed R33.9S — Synthetic presenting concern at the index visit, superseded by the urethrogram and cystoscopy diagnosis; his documented lifelong retention and self-treatment with bougies are echoed.
Delusional disorder, persecutory type (DSM-5-TR), of about nine years' duration, with non-bizarre beliefs of a coordinated campaign against him; no hallucinations, disorganization, or mood episode; normal cognition; insomnia secondary to preoccupation; synthetic modern counterpart of his documented persecutory beliefsactiveconfirmed F22S — Synthetic modern diagnosis. His beliefs and conduct are documented (D); calling them a paranoid delusion is a retrospective interpretation (R), made difficult by the real persecution he suffered.
Bulbar urethral stricture, 1.5 cm, dense and ring-like (lumen about 8 French), idiopathic and probably congenital in origin, with decades of self-dilation; bladder trabeculation without hydronephrosis; kidney function normal; synthetic modern counterpart of his documented lifelong urinary retentionactiveconfirmed N35.812S — Synthetic modern diagnosis. His lifelong retention is documented (D); its cause is disputed (R), and the autopsy found no urethral lesion (D), so this stricture is not presented as his historical diagnosis.
Right inguinal hernia, reducible and minimally symptomatic, likely aggravated by years of straining to pass urineactiveconfirmed K40.90S — Synthetic finding on examination; it echoes the documented rupture of 1758, whose site the source does not state.
Acute low back strain after splitting firewood, without sciatica, red flags, or urinary retention (bladder scan 20 mL); resolved within three weeksresolvedconfirmed S39.012AS — Synthetic common injury; the wood-splitting echoes a documented habit (CLM-0020), but no back injury is documented.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveySuicide and violence risk review (C-SSRS Since Last Visit, PHQ-9 item 9, thoughts of harming others, plans to confront anyone, access to weapons) and the safety planEvery visitCompleted todayNo thoughts of suicide or of harming anyone; no plan to confront anyone; no weapons; PHQ-9 item 9 scored 0; safety plan reviewed
SurveyPHQ-9 for depressive symptomsAt least monthlyCompleted today4, down from 8 at intake; monthly scores of 5 and 4 recorded at CBT sessions
ExaminationWeight four weeks after starting aripiprazoleWeight at 4, 8, and 12 weeksDeferredMissed: the four-week weight was not taken because he was away and no visit was booked. The weight at seven weeks (64.0 kg, at the sick visit) and today's weight (64.4 kg, up 1.9 percent) show no clinically important gain, so no harm resulted. Corrective action: future early weight checks will be booked as nurse visits at the time a drug is started
ExaminationWeight, BMI, waist, and blood pressure at twelve weeksWeight at 12 weeks then quarterly; waist and blood pressure at 12 weeks then yearlyCompleted today64.4 kg, BMI 23.4, waist 93 cm, 124/78 mmHg
LaboratoryFasting glucose, hemoglobin A1c, and lipids at twelve weeksBaseline, 12 weeks, then yearlyCompleted todayGlucose 94 mg/dL, A1c 5.5 percent, total cholesterol 201, HDL 47, LDL 126, triglycerides 138 mg/dL
ExaminationAkathisia checkEach visit on an antipsychoticCompleted todayNone
ExaminationAIMSBaseline and every 6 monthsDueNext at six months on aripiprazole
Medication safetyAdherence and adverse-effect reviewEvery visitCompleted todayNo missed doses; no nausea, restlessness, or impulse-control symptoms
ReferralCognitive behavioral therapy for psychosisAbout 16 sessionsCompleted todayFourteen sessions; two more planned with a relapse-prevention plan
SurveyIPSS and quality-of-life scoreAt each surveillance visitCompleted todayIPSS 5; quality of life 1
ImagingUroflowmetry and post-void residualAbout 3, 6, and 12 months after urethroplastyCompleted todayMaximum flow 20.8 mL/s; residual 30 mL
ImagingUrethroscopy or urethrogramOnly with symptoms or a fall in flowNot indicatedNo symptoms and a normal flow
LaboratoryCreatinine and eGFRYearly after relief of obstruction, or with symptomsCompleted today0.99 mg/dL; eGFR 91
ExaminationInguinal hernia checkAt each review while under watchful waitingCompleted todayUnchanged

Goal progress:

Guideline basis: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition. Am J Psychiatry 2020;177(9):868-872 (2020); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (PHQ-9, suicide-risk review, and second-generation antipsychotic monitoring) (2026); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Urethral Stricture Disease: AUA Guideline Amendment (2023). Wessells H, et al. J Urol 2023;210(1):64-71. PMID 37096574 (2023); International guidelines for groin hernia management. HerniaSurge Group. Hernia 2018;22(1):1-165 (2018)

Follow-up: Last two CBT sessions; urology flow test at six months; weight in three months; preventive visit in the autumn. Next scheduled visit 2026-09-22: adult preventive visit. [S]